Koninklijke DSM N.V.
Koninklijke DSM N.V. DSM.AS Peers
See (DSM.AS) competitors and their performances in Stock Market.
Peer Comparison Table: Chemicals - Specialty Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DSM.AS | €114.05 | N/A | 763.7M | 18.25 | €6.25 | N/A |
| AI.PA | €183.46 | -0.47% | 105.8B | 32.13 | €5.71 | +1.80% |
| AKZA.AS | €58.26 | -0.38% | 9.9B | 21.42 | €2.72 | +3.40% |
| IMCD.AS | €117.25 | +0.34% | 6.9B | 24.13 | €4.86 | +1.83% |
| AKE.PA | €60.30 | -0.90% | 4.6B | 15.74 | €3.83 | +5.97% |
| AZE.BR | €13.86 | -0.36% | 3.4B | 18.73 | €0.74 | +1.59% |
| OCI.AS | €7.51 | -2.28% | 1.6B | -11.04 | -€0.68 | +217.85% |
| CRBN.AS | €20.08 | +1.98% | 1.2B | 26.08 | €0.77 | +3.19% |
| EXPL.PA | €200.00 | +8.11% | 420.6M | 19.74 | €10.13 | +0.50% |
| AVTX.AS | €14.42 | +1.19% | 126.9M | -4.00 | -€3.60 | N/A |
Stock Comparison
DSM.AS vs AI.PA Comparison
DSM.AS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSM.AS stands at 763.7M. In comparison, AI.PA has a market cap of 105.8B. Regarding current trading prices, DSM.AS is priced at €114.05, while AI.PA trades at €183.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSM.AS currently has a P/E ratio of 18.25, whereas AI.PA's P/E ratio is 32.13. In terms of profitability, DSM.AS's ROE is +0.05%, compared to AI.PA's ROE of +0.13%. Regarding short-term risk, DSM.AS is more volatile compared to AI.PA. This indicates potentially higher risk in terms of short-term price fluctuations for DSM.AS.
DSM.AS vs AKZA.AS Comparison
DSM.AS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSM.AS stands at 763.7M. In comparison, AKZA.AS has a market cap of 9.9B. Regarding current trading prices, DSM.AS is priced at €114.05, while AKZA.AS trades at €58.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSM.AS currently has a P/E ratio of 18.25, whereas AKZA.AS's P/E ratio is 21.42. In terms of profitability, DSM.AS's ROE is +0.05%, compared to AKZA.AS's ROE of +0.10%. Regarding short-term risk, DSM.AS is more volatile compared to AKZA.AS. This indicates potentially higher risk in terms of short-term price fluctuations for DSM.AS.
DSM.AS vs IMCD.AS Comparison
DSM.AS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSM.AS stands at 763.7M. In comparison, IMCD.AS has a market cap of 6.9B. Regarding current trading prices, DSM.AS is priced at €114.05, while IMCD.AS trades at €117.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSM.AS currently has a P/E ratio of 18.25, whereas IMCD.AS's P/E ratio is 24.13. In terms of profitability, DSM.AS's ROE is +0.05%, compared to IMCD.AS's ROE of +0.14%. Regarding short-term risk, DSM.AS is less volatile compared to IMCD.AS. This indicates potentially lower risk in terms of short-term price fluctuations for DSM.AS.
DSM.AS vs AKE.PA Comparison
DSM.AS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSM.AS stands at 763.7M. In comparison, AKE.PA has a market cap of 4.6B. Regarding current trading prices, DSM.AS is priced at €114.05, while AKE.PA trades at €60.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSM.AS currently has a P/E ratio of 18.25, whereas AKE.PA's P/E ratio is 15.74. In terms of profitability, DSM.AS's ROE is +0.05%, compared to AKE.PA's ROE of +0.05%. Regarding short-term risk, DSM.AS is less volatile compared to AKE.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DSM.AS.
DSM.AS vs AZE.BR Comparison
DSM.AS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSM.AS stands at 763.7M. In comparison, AZE.BR has a market cap of 3.4B. Regarding current trading prices, DSM.AS is priced at €114.05, while AZE.BR trades at €13.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSM.AS currently has a P/E ratio of 18.25, whereas AZE.BR's P/E ratio is 18.73. In terms of profitability, DSM.AS's ROE is +0.05%, compared to AZE.BR's ROE of +0.06%. Regarding short-term risk, DSM.AS is less volatile compared to AZE.BR. This indicates potentially lower risk in terms of short-term price fluctuations for DSM.AS.
DSM.AS vs OCI.AS Comparison
DSM.AS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSM.AS stands at 763.7M. In comparison, OCI.AS has a market cap of 1.6B. Regarding current trading prices, DSM.AS is priced at €114.05, while OCI.AS trades at €7.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSM.AS currently has a P/E ratio of 18.25, whereas OCI.AS's P/E ratio is -11.04. In terms of profitability, DSM.AS's ROE is +0.05%, compared to OCI.AS's ROE of -0.11%. Regarding short-term risk, DSM.AS is less volatile compared to OCI.AS. This indicates potentially lower risk in terms of short-term price fluctuations for DSM.AS.
DSM.AS vs CRBN.AS Comparison
DSM.AS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSM.AS stands at 763.7M. In comparison, CRBN.AS has a market cap of 1.2B. Regarding current trading prices, DSM.AS is priced at €114.05, while CRBN.AS trades at €20.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSM.AS currently has a P/E ratio of 18.25, whereas CRBN.AS's P/E ratio is 26.08. In terms of profitability, DSM.AS's ROE is +0.05%, compared to CRBN.AS's ROE of +0.07%. Regarding short-term risk, DSM.AS is less volatile compared to CRBN.AS. This indicates potentially lower risk in terms of short-term price fluctuations for DSM.AS.
DSM.AS vs EXPL.PA Comparison
DSM.AS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSM.AS stands at 763.7M. In comparison, EXPL.PA has a market cap of 420.6M. Regarding current trading prices, DSM.AS is priced at €114.05, while EXPL.PA trades at €200.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSM.AS currently has a P/E ratio of 18.25, whereas EXPL.PA's P/E ratio is 19.74. In terms of profitability, DSM.AS's ROE is +0.05%, compared to EXPL.PA's ROE of +0.15%. Regarding short-term risk, DSM.AS is less volatile compared to EXPL.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DSM.AS.
DSM.AS vs AVTX.AS Comparison
DSM.AS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSM.AS stands at 763.7M. In comparison, AVTX.AS has a market cap of 126.9M. Regarding current trading prices, DSM.AS is priced at €114.05, while AVTX.AS trades at €14.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSM.AS currently has a P/E ratio of 18.25, whereas AVTX.AS's P/E ratio is -4.00. In terms of profitability, DSM.AS's ROE is +0.05%, compared to AVTX.AS's ROE of -0.43%. Regarding short-term risk, DSM.AS is less volatile compared to AVTX.AS. This indicates potentially lower risk in terms of short-term price fluctuations for DSM.AS.
DSM.AS vs ALCRB.PA Comparison
DSM.AS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSM.AS stands at 763.7M. In comparison, ALCRB.PA has a market cap of 125.8M. Regarding current trading prices, DSM.AS is priced at €114.05, while ALCRB.PA trades at €7.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSM.AS currently has a P/E ratio of 18.25, whereas ALCRB.PA's P/E ratio is -3.80. In terms of profitability, DSM.AS's ROE is +0.05%, compared to ALCRB.PA's ROE of -0.16%. Regarding short-term risk, DSM.AS is less volatile compared to ALCRB.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DSM.AS.
DSM.AS vs HOLCO.AS Comparison
DSM.AS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSM.AS stands at 763.7M. In comparison, HOLCO.AS has a market cap of 95.5M. Regarding current trading prices, DSM.AS is priced at €114.05, while HOLCO.AS trades at €111.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSM.AS currently has a P/E ratio of 18.25, whereas HOLCO.AS's P/E ratio is 16.20. In terms of profitability, DSM.AS's ROE is +0.05%, compared to HOLCO.AS's ROE of +0.10%. Regarding short-term risk, DSM.AS is less volatile compared to HOLCO.AS. This indicates potentially lower risk in terms of short-term price fluctuations for DSM.AS.
DSM.AS vs ALAFY.PA Comparison
DSM.AS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSM.AS stands at 763.7M. In comparison, ALAFY.PA has a market cap of 75.1M. Regarding current trading prices, DSM.AS is priced at €114.05, while ALAFY.PA trades at €2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSM.AS currently has a P/E ratio of 18.25, whereas ALAFY.PA's P/E ratio is -7.84. In terms of profitability, DSM.AS's ROE is +0.05%, compared to ALAFY.PA's ROE of -0.18%. Regarding short-term risk, DSM.AS is less volatile compared to ALAFY.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DSM.AS.
DSM.AS vs ALKEM.PA Comparison
DSM.AS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSM.AS stands at 763.7M. In comparison, ALKEM.PA has a market cap of 54.6M. Regarding current trading prices, DSM.AS is priced at €114.05, while ALKEM.PA trades at €3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSM.AS currently has a P/E ratio of 18.25, whereas ALKEM.PA's P/E ratio is -38.75. In terms of profitability, DSM.AS's ROE is +0.05%, compared to ALKEM.PA's ROE of -0.05%. Regarding short-term risk, DSM.AS is more volatile compared to ALKEM.PA. This indicates potentially higher risk in terms of short-term price fluctuations for DSM.AS.
DSM.AS vs ORAP.PA Comparison
DSM.AS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSM.AS stands at 763.7M. In comparison, ORAP.PA has a market cap of 42.3M. Regarding current trading prices, DSM.AS is priced at €114.05, while ORAP.PA trades at €6.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSM.AS currently has a P/E ratio of 18.25, whereas ORAP.PA's P/E ratio is -1.59. In terms of profitability, DSM.AS's ROE is +0.05%, compared to ORAP.PA's ROE of -0.78%. Regarding short-term risk, DSM.AS is more volatile compared to ORAP.PA. This indicates potentially higher risk in terms of short-term price fluctuations for DSM.AS.
DSM.AS vs MLPFX.PA Comparison
DSM.AS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSM.AS stands at 763.7M. In comparison, MLPFX.PA has a market cap of 20M. Regarding current trading prices, DSM.AS is priced at €114.05, while MLPFX.PA trades at €14.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSM.AS currently has a P/E ratio of 18.25, whereas MLPFX.PA's P/E ratio is 43.71. In terms of profitability, DSM.AS's ROE is +0.05%, compared to MLPFX.PA's ROE of +0.17%. Regarding short-term risk, DSM.AS is more volatile compared to MLPFX.PA. This indicates potentially higher risk in terms of short-term price fluctuations for DSM.AS.
DSM.AS vs ALKOM.PA Comparison
DSM.AS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSM.AS stands at 763.7M. In comparison, ALKOM.PA has a market cap of 12.1M. Regarding current trading prices, DSM.AS is priced at €114.05, while ALKOM.PA trades at €1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSM.AS currently has a P/E ratio of 18.25, whereas ALKOM.PA's P/E ratio is -101.00. In terms of profitability, DSM.AS's ROE is +0.05%, compared to ALKOM.PA's ROE of -0.01%. Regarding short-term risk, DSM.AS is more volatile compared to ALKOM.PA. This indicates potentially higher risk in terms of short-term price fluctuations for DSM.AS.
DSM.AS vs ALVIN.PA Comparison
DSM.AS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSM.AS stands at 763.7M. In comparison, ALVIN.PA has a market cap of 11.5M. Regarding current trading prices, DSM.AS is priced at €114.05, while ALVIN.PA trades at €3.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSM.AS currently has a P/E ratio of 18.25, whereas ALVIN.PA's P/E ratio is -3.95. In terms of profitability, DSM.AS's ROE is +0.05%, compared to ALVIN.PA's ROE of -2.77%. Regarding short-term risk, DSM.AS is more volatile compared to ALVIN.PA. This indicates potentially higher risk in terms of short-term price fluctuations for DSM.AS.
DSM.AS vs ALDUB.PA Comparison
DSM.AS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSM.AS stands at 763.7M. In comparison, ALDUB.PA has a market cap of 8.2M. Regarding current trading prices, DSM.AS is priced at €114.05, while ALDUB.PA trades at €2.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSM.AS currently has a P/E ratio of 18.25, whereas ALDUB.PA's P/E ratio is -7.11. In terms of profitability, DSM.AS's ROE is +0.05%, compared to ALDUB.PA's ROE of -0.08%. Regarding short-term risk, DSM.AS is less volatile compared to ALDUB.PA. This indicates potentially lower risk in terms of short-term price fluctuations for DSM.AS.
DSM.AS vs MLPRX.PA Comparison
DSM.AS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSM.AS stands at 763.7M. In comparison, MLPRX.PA has a market cap of 1.7M. Regarding current trading prices, DSM.AS is priced at €114.05, while MLPRX.PA trades at €0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSM.AS currently has a P/E ratio of 18.25, whereas MLPRX.PA's P/E ratio is -15.90. In terms of profitability, DSM.AS's ROE is +0.05%, compared to MLPRX.PA's ROE of -0.01%. Regarding short-term risk, DSM.AS is more volatile compared to MLPRX.PA. This indicates potentially higher risk in terms of short-term price fluctuations for DSM.AS.
DSM.AS vs REC.BR Comparison
DSM.AS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DSM.AS stands at 763.7M. In comparison, REC.BR has a market cap of 0. Regarding current trading prices, DSM.AS is priced at €114.05, while REC.BR trades at €16.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DSM.AS currently has a P/E ratio of 18.25, whereas REC.BR's P/E ratio is N/A. In terms of profitability, DSM.AS's ROE is +0.05%, compared to REC.BR's ROE of +0.15%. Regarding short-term risk, DSM.AS is less volatile compared to REC.BR. This indicates potentially lower risk in terms of short-term price fluctuations for DSM.AS.